GLEN ALLEN, Va., May 7, 2024 /CNW/ -- Remidio Inc., a health technology innovator developing cutting-edge technology to combat global blindness from Diabetic Retinopathy, Glaucoma, AMD, & Cataracts, ...

GLEN ALLEN, Va., July 7, 2022 /CNW/ -- Glaucoma, one of the world's leading causes of irreversible blindness, is expected to affect an estimated 120 million by 2040, globally. Treatment options for ...

World's first Smartphone based offline AI expands geographical scope to deliver convenience and increase access to DR screening. BANGALORE, India, Feb. 23, 2023 /PRNewswire/ -- Remidio has received CE ...

New Delhi: In a move set to redefine non-invasive disease detection, Remidio, a global leader in AI-powered ophthalmic solutions, has invested in Occuity, a UK-based developer of handheld, optical ...

BENGALURU: Anand Sivaraman met Anand Vinekar in a train coming from Coimbatore to Bengaluru, where they both lived. Sivaraman, a PhD in chemical engineering, was working with biotech firm Reametrix.

India’s healthcare challenge is not a problem of capacity. It is one of access and distribution. Even as our national average doctor-to-population ratio appears to be ‘adequate’, there is a severe ...

Mumbai: Medical device maker Remidio Innovative Solutions has launched an automated optical biometry and autorefraction system aimed at improving accuracy and consistency in pediatric myopia ...

BANGALORE, India, Feb. 23, 2023 /PRNewswire/ -- Remidio has received CE mark approval for its Medios AI, to detect Referable DR. This approval closely follows the nod the AI received from Singapore's ...